908 related items for PubMed ID: 11100276
1. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N.
Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
[Abstract] [Full Text] [Related]
2. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[Abstract] [Full Text] [Related]
3. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R, Moos M, Möhle R, Döhner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W.
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[Abstract] [Full Text] [Related]
4. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
Cairoli R, Grillo G, Tedeschi A, Gargantini L, Marenco P, Tresoldi E, Barbarano L, Nosari AM, Morra E.
Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
[Abstract] [Full Text] [Related]
5. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V.
Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
[Abstract] [Full Text] [Related]
6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB.
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[Abstract] [Full Text] [Related]
7. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N.
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[Abstract] [Full Text] [Related]
8. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C, Gressin R, Lucas V, Colombat P, Harousseau JL, Groupe Ouest-Est des Leucémies et des Autres Maladies du Sang.
N Engl J Med; 2004 Mar 25; 350(13):1287-95. PubMed ID: 15044639
[Abstract] [Full Text] [Related]
9. The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
Galimberti S, Marasca R, Caracciolo F, Fazzi R, Papineschi F, Benedetti E, Guerrini F, Morabito F, Oliva E, Di Renzo N, Federico M, Petrini M, Torelli G, For GISL.
Bone Marrow Transplant; 2002 Apr 25; 29(7):581-7. PubMed ID: 11979307
[Abstract] [Full Text] [Related]
10. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW, van der Holt B, Mackenzie MA, Van't Veer MB, Wijermans PW, Ossenkoppele GJ, Schouten HC, Sonneveld P, Steijaert MM, Kluin PM, Kluin-Nelemans HC, Verdonck LF, Dutch-Belgian Hemato-Oncology Cooperative Group.
J Clin Oncol; 2005 Jun 01; 23(16):3793-801. PubMed ID: 15809447
[Abstract] [Full Text] [Related]
11. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
Mahé B, Milpied N, Mellerin MP, Moreau P, Morineau N, Vigier M, Harousseau JL.
Bone Marrow Transplant; 2003 Mar 01; 31(6):467-73. PubMed ID: 12665842
[Abstract] [Full Text] [Related]
12. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
Verdonck LF, van Putten WL, Hagenbeek A, Schouten HC, Sonneveld P, van Imhoff GW, Kluin-Nelemans HC, Raemaekers JM, van Oers RH, Haak HL.
N Engl J Med; 1995 Apr 20; 332(16):1045-51. PubMed ID: 7898521
[Abstract] [Full Text] [Related]
13. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
González-Barca E, Fernández de Sevilla A, Domingo-Claros A, Romagosa V, Martín-Henao GA, De Sanjose S, Carmona M, Petit J, García J, Grañena A.
Bone Marrow Transplant; 2000 Nov 20; 26(10):1051-6. PubMed ID: 11108302
[Abstract] [Full Text] [Related]
14. Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.
Moreau P, Milpied N, Voillat L, Colombat P, Mahé B, Rapp MJ, Moreau A, Dupas B, Bulabois CE, Juge-Morineau N, Harousseau JL.
Bone Marrow Transplant; 1998 Jun 20; 21(12):1193-6. PubMed ID: 9674850
[Abstract] [Full Text] [Related]
15. Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial.
Ladetto M, Vallet S, Benedetti F, Vitolo U, Martelli M, Callea V, Patti C, Coser P, Perrotti A, Sorio M, Boccomini C, Pulsoni A, Stelitano C, Scimè R, Boccadoro M, Rosato R, De Marco F, Zanni M, Corradini P, Tarella C.
Leukemia; 2006 Oct 20; 20(10):1840-7. PubMed ID: 16932351
[Abstract] [Full Text] [Related]
16. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
Colombat P, Guilhot F, Bordesoule D, Renou P, Benz-Lemoine E, Fouillard L, Drouet M, Tanzer J, Lamagnere JP.
Haematologica; 1991 Oct 20; 76(6):479-84. PubMed ID: 1726492
[Abstract] [Full Text] [Related]
17. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H.
Eur J Haematol; 2000 Jul 20; 65(1):17-22. PubMed ID: 10914935
[Abstract] [Full Text] [Related]
18. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Martelli M, Vignetti M, Zinzani PL, Gherlinzoni F, Meloni G, Fiacchini M, De Sanctis V, Papa G, Martelli MF, Calabresi F, Tura S, Mandelli F.
J Clin Oncol; 1996 Feb 20; 14(2):534-42. PubMed ID: 8636768
[Abstract] [Full Text] [Related]
19. Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study.
Linassier C, Fouillard L, Milpied N, Tilly H, Pico J, Abgrall JF, Coiffier B, Herbrecht R, Biron P, Colombat P.
Cancer Detect Prev; 1996 Feb 20; 20(1):11-9. PubMed ID: 8907199
[Abstract] [Full Text] [Related]
20. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Reece DE, Brockington DA, Phillips GL, Barnett MJ, Klingemann HG, Nantel SH, Sutherland HJ, Shepherd JD.
Bone Marrow Transplant; 2000 Sep 20; 26(6):621-6. PubMed ID: 11041567
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
